Cairo University
cu.edu.egTotal trials
4,426
Capped at 5,000
Active
1,064
Phase 3
198
Total enrollment
1,623,236
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 40 of 262 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dexmedetomidine | 28 | ||||||
| Dexamethasone | — | 11 | |||||
| Norepinephrine | — | — | — | 8 | |||
| intravenous tranexamic acid | — | — | — | — | 5 | ||
| Control group | — | — | — | — | 5 | ||
| bupivacaine 0.25% | — | — | — | — | 3 | ||
| Methotrexate | — | — | — | 4 | |||
| Lactoferrin | — | — | — | 4 | |||
| Metformin Hydrochloride 500 MG | — | — | — | — | 2 | ||
| Lidocaine-Prilocaine Topical | — | — | — | — | — | 1 | |
| Saline spray | — | — | — | — | — | 1 | |
| Antivet | — | — | — | — | — | 1 | |
| opalustre | — | — | — | — | — | 1 | |
| Ephedrine and Norepinephrine | — | — | — | — | — | 1 | |
| intralesional vitamin D3 versus intralesional acyclovir | — | — | — | — | — | 1 | |
| oral Iron | — | — | — | — | — | 1 | |
| lactoferrin and oral iron | — | — | — | — | — | 1 | |
| Oral ondansetron strips | — | — | — | — | — | 1 | |
| dexamethasone 2 mg in bupivacaine 0.25% | — | — | — | — | — | 1 | |
| Acetazolamide | — | — | — | — | — | 1 | |
| Metolazone | — | — | — | — | — | 1 | |
| IV Loop Diuretics | — | — | — | — | — | 1 | |
| bupivacaine 0.125% | — | — | — | — | — | 1 | |
| Lidocaine group | — | — | — | — | — | 1 | |
| Magnesium group | — | — | — | — | — | 1 | |
| Giomer pit and fissure sealant without etching | — | — | — | — | — | 1 | |
| Giomer pit and fissure sealant with etching | — | — | — | — | — | 1 | |
| Menaquinone | — | — | — | — | — | 1 | |
| Autogenous Demineralized Dentin Graft | — | — | — | — | — | 1 | |
| Autogenous Bone Graft | — | — | — | — | — | 1 | |
| Application of crisaborole twice daily | — | — | — | — | — | 1 | |
| Tacrolimus ointment in atopic dermatitis | — | — | — | — | — | 1 | |
| Diacerein | — | — | — | — | — | 1 | |
| Combination of methotrexate and escitalopram in treatment of psoriasis patients with depression and/or anxiety | — | — | — | — | — | 1 | |
| nebulized tranexamic acid | — | — | — | — | — | 1 | |
| Weight-based dosing | — | — | — | — | — | 1 | |
| Age-based dosing | — | — | — | — | — | 1 | |
| Propofol | — | 10 | |||||
| Biodentine | — | — | 4 | ||||
| oral mini pulse | — | — | — | — | 2 |
222 more active programs hidden
Next readouts
- 2024-05-01
- 2024-06-01
- 2024-06-28
- 2024-06-30
- 2024-08
- 2024-08-15
- 2024-08-30
- 2024-09-01
- 2024-09-01
- 2024-09-01
Top conditions
- Dental Caries63
- Postoperative Pain50
- Cerebral Palsy44
- Infertility31
- Obesity30
- Low Back Pain29
- Pain26
- Stroke26
Frequently asked questions about Cairo University
- How many clinical trials does Cairo University have on ClinicalTrials.gov?
- Cairo University is listed as the lead sponsor on 4,426 clinical trials in ClinicalTrials.gov, 1,064 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Cairo University's trials are in Phase 3?
- 198 of Cairo University's trials are in Phase 3, spread across 262 active drug programs.
- What therapeutic areas does Cairo University focus on?
- Cairo University's most-studied conditions on ClinicalTrials.gov are Dental Caries, Postoperative Pain, Cerebral Palsy, Infertility, Obesity.
- When are Cairo University's next clinical trial readouts?
- Cairo University has 10 upcoming primary-completion readouts tracked here; the soonest is “Retention Rate of Giomer Pit and Fissure Sealant Applied With or Without Etching”, expected around 2024-05-01.